Patrick Aldrin-Kirk Joins rAAVen as Chief Scientific Officer

rAAVen Therapeutics hires Patrick Aldrin-Kirk, PhD as its new Chief Scientific Officer. Before joining rAAVen, Patrick did his postdoc and held a position as Associate Professor at Copenhagen University, Denmark.